Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Individual approach to success psychopharmacotherapy in patient with delusional body dysmorphic disorder (CROSBI ID 564167)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Grahovac, Tanja ; Pavešić-Radonja, Aristea ; Rončević-Gržeta, Ika ; Ružić, Klementina Individual approach to success psychopharmacotherapy in patient with delusional body dysmorphic disorder // European psychiatry / European Psychiatric Association (ur.). 2010. str. 601 (P01-388)-601 (P01-388)

Podaci o odgovornosti

Grahovac, Tanja ; Pavešić-Radonja, Aristea ; Rončević-Gržeta, Ika ; Ružić, Klementina

engleski

Individual approach to success psychopharmacotherapy in patient with delusional body dysmorphic disorder

Introduction: Delusional disorder is characterized in current classifications by the development of one delusional thought or set of related delusional ideas that are usually permanent. Body dysmorphic disorder is sick preoccupation with appearance of the whole body or focused on particular areas of body, when the patient is convinced that there is a change of shape, structure or function. Objectives: We will present 36-year old patient who was sent to a psychiatry recommended by the otorinolaringology specialist, where he was treated three years for sore throat. The patient was very focused and concerned about the problems of the target organ. Aim: Correct diagnosis is very important for choosing adequate therapy. Methods: clinical interview, psychologic testing, EEG egzam. Results: He was treated with different combinations of drugs, but the combined therapy showed that the most effective were quetiapin, venlafaksin and valproat acid. Conclusion: Individual access and knowledge of the pathophysiological background of patients with delusional body dysmorphic disorder is of great importance in choosing psycho pharmacotherapy.

body dysmorphic disorder ; psychopharmacotherapy

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

601 (P01-388)-601 (P01-388).

2010.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

European psychiatry

European Psychiatric Association

München: Essex Pharma, Elsevier

0924-9338

Podaci o skupu

18th European Congress of Psychiatry

poster

27.02.2010-02.03.2010

München, Njemačka

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost